2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing education credits & complete the evaluation upon completion of the Symposium Turn all cell phones/pagers to vibrate Refreshments provided throughout the program

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Thank You Jeffrey Albaugh, PhD,APRN, CUCNS Robert Chapman, MD Carol Christner Terry Foster Jerry Lee Hardy Elisabeth Heath, MD Joe Ezell Bester King Kristen Kingzett, MD Steven Lucas, MD Jordan Maier, MD Ruthie Maples, MSW Michael Poole Isaac Powell, MD Roderick Samuels Virgil Simons Kathryn Smolinski Jeffrey Triest, MD Ulka Vaishampayan, MD

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Thank You to Our Sponsors Abbott Astellas Dendreon Endo Pharmaceuticals Ferring Pharmaceutical Janssen Biotec Medivation Millennium Sanofi-Aventis Veridex

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Virgil Simons, MPA, MBA Founder & President The Prostate Net

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Health Initiatives in the Era of Healthcare Reform: Can We Afford the Care We Need

Prostate Cancer in America $11 Billion Spent on Care U. S. Population Is Aging New Therapeutics Come at a High Price Quality Adjusted Life Year (QALY) Standards Value  $ Spent: Who Determines

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Do We Pay to Die or Invest to Live

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Carol Christner Director, Government Relations Karmanos Cancer Institute

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Politics and Prostates Oral Chemotherapy Access

Oral Chemotherapies Biualutamide (Casodex ®),Flutamide (Eulexin®),Niutamide (Nilandron®) Oral chemotherapies work by targeting and attacking only cancer cells. 10% of available chemotherapies 25 – 35% of medications in the oncology development pipeline.

Intravenous vs Oral Chemotherapy Insurance Coverage 1.Intravenous/Injected – Typically covered under “Medical Benefit” – Office visit co-pay – No fee for the drug 2.Oral – Typically covered under “Pharmacy Benefit” – Highest tier of plan’s cost-sharing system – Co-pay can be percentage of drug cost

Michigan Senate Bills and House Bills Bills do NOT: – Mandate coverage of oral or IV chemotherapy. – Require health plans to have a pharmacy benefit. Bills DO: – Require that oral and IV chemotherapies be covered in the same manner. – Ensure that patients have real access to the medications deemed most appropriate by their physician.

2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Rodrick Samuels National Salon and Barber Educator Profile Barber Institute/The Andis Company

Who in the Prostate is Rodrick Samuels?

Cutting Out Prostate Cancer with your host…Rodrick Samuels? National Educator Philanthropist School Owner Master Barber Mentor Business Developer Lover of Health Prostates

Social Media is social…STALK ME!

Improving doctor-patient communication

Doctors need to hear patients desires for quality of life

Patients need to understand what the doctor is telling them

Treatment and Life after Cancer Doctors…Patients…

2011 PROSTATE CANCER STATISTICS SUMMARY 240,890 New Cases 33,720 Deaths a Year 92 Deaths a Day 4 Deaths an Hour

Barber Shops Impact the Community The place to be Place of security and comfort Cultural institution An avenue to disseminate health education information

THE ROI… Information conduit for the medical community Increased service for the client community Enhanced leadership profile for the Med Ctr. Better service interaction between communities Increased Med Ctr. traffic/revenue/market share Increased Clinical Trial accrual Barber satisfaction in being an agent for change

2 nd Annual Prostate Cancer Symposium Patient Doctor Communication Building Effective Disease Management Dialogues 9/22/12 9/22/12

Prostate Cancer at HFH Prostate Cancer at HFH Stage at Diagnosis –I: 13.6% –II: 71.9% –III: 5.9% –IV: 5.2% –UKN: 3.4% Stage at Diagnosis –I: 13.7% –II: 66.2% –III: 4.4% –IV: 10.5% –UKN: 5.2%

Communication Opportunities Communication Opportunities In the Lay Community –Within the Family –Through church or place for religious gathering –Education through the workplace Primary Care –Screening decisions Specialty Care –Diagnostic, Staging, and treatment decisions

One Approach One Approach Question Prompt List (QPL) Development –Lay Community input –Physician review Randomized Prospective testing –Usual care v QPL v QPL + Counseling –Videotaping and analyzing Dr. / Patient discussion during decision making visits